Skip to main navigation

Executing for success - Ernst & Young - Venezuela

Executing for success

Surviving the current economic turbulence has added new challenges and complexity to an industry already weakened by anaemic R&D output, increased pricing pressures and shifting stakeholder expectations. As pharmaceutical leaders face critical strategic choices -- choices that have the potential to change everything about today’s “big pharma” business model -- there is an urgency to accelerate change.

Ernst & Young’s Global Pharmaceutical Center brings together our worldwide team of professionals to help you achieve your potential -- a team with deep experience in providing assurance, tax, transaction and advisory services to pharmaceutical companies around the globe. As pharmaceutical companies strive for transformational strategies to both create and sustain value, we can help you move forward and lay the groundwork for an enduring enterprise.

We also publish a series of industry-leading reports and articles that provide timely points of view on business issues from around the world. So you get practical advice on the right way forward for your organization.

The excitement around new science and technologies, the encouraging demographics of the global population, the improving standard of living and longer life spans enjoyed by many countries, all point to a wealth of opportunities ahead. We look forward to working with you as you execute for success.

Aprendamos del cambio: la industria de las ciencias biológicas

¿Cómo administrar su compañía durante la recesión y colocarla en buena posición para el crecimiento? Después de entrevistar a miles de ejecutivos de ciencias biológicas, identificamos algunos temas predominantes. Desde gestionar los riesgos hasta mejorar la asignación de capital, revelamos las lecciones que podrían marcar la diferencia entre sobrevivir y prosperar en el nuevo entorno económico.

 

 

Ernst & Young Online

Aprenda más
Aprenda más

Return to Login

 
Back to top